Navigation Links
MedQuist Reports First Quarter 2008 Results
Date:5/12/2008

54

Accrued expenses 18,492 18,989

Accrued compensation 13,815 14,826

Customer accommodation and quantification 17,596 18,459

Deferred income tax liability - current 4,783 4,783

Deferred revenue 17,486 16,023

Total current liabilities 82,376 85,834

Deferred income taxes 15,862 15,151

Other non-current liabilities 2,055 2,143

Shareholders' equity:

Common stock - no par value; authorized 60,000

shares; 37,544 and 37,544 shares issued and

outstanding, respectively 236,504 236,412

Retained earnings 68,459 72,876

Accumulated other comprehensive income 5,252 5,356

Total shareholders' equity 310,215 314,644

Total liabilities and shareholders' equity $410,508 $417,772

MedQuist Inc. and Subsidiaries

Consolidated Statements of Cash Flows

(In thousands)

Unaudited

Three months ended

March 31,

2008 2007

Operating activities:

Net loss $(4,417) $(1,886)

Adjustments to reconcile net loss to cash

provided by (used in) operating activities:

Depreciation and amortization 4,289 3,885

Equity in income of affiliated company (16) (260)<
'/>"/>

SOURCE MedQuist Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. QLT reports initial proof of concept data for punctal plug delivery technology
2. Neurobiological Technologies Reports Third Quarter Financial Results
3. Bionovo Reports First Quarter 2008 Financial Results
4. WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders Meeting
5. Cardium Reports on First Quarter 2008 Highlights and Financial Results
6. Novavax Reports First Quarter 2008 Financial Results
7. Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
8. Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
9. Pharmos Corporation Reports 2008 First Quarter Results
10. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
11. Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...v. 20 Veridiam (www.veridiam.com) ...company category at the 2009 Workplace Excellence ...Society for Human Resources Management and recogni...tices. ,, Veridiam was one of nine winners, sel...ies, honored at the recent awards ceremony. San Di...
(Date:11/20/2009)...Md., Nov. 20 Novavax, In...iced an underwritten public offering of 6,800,000 ...c of $3.30 per share. The approximately $21 milli...ng discounts and commissions, will be used for pre...sed vaccines, internal research and development pr...
(Date:11/20/2009)...Nov. 20 Cell Therapeutic...ay that the Ninth Circuit Court of Appeals reverse...hould be allowed to pursue all of its claims again...strict Court for trial. CTI filed a complaint aga...bursement consultant for CTI,s product TRISENOX, i...
(Date:11/20/2009)... METTLER TOLEDO recently announced that Dr. Domin...The Role of Process Analytical Technology (PAT) in...ecember 1, 2009. , (PRWEB...cess Analytical Technology (PAT) in Green Chemistr...ocess Analytical Technology (PAT) case studies wil...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Novavax Prices Public Offering of Common Stock 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2
... Therapies to Address the Underlying Cause of Cyst... Paradigm -, SOUTH PLAINFIELD, N.J., Aug. 20 New...hat the investigational oral drug,PTC124 demonstra...(CF). The,data show that treatment with PTC124 res...the chloride channel function of patients with,non...
...PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq:,...a letter from The Nasdaq,Stock Market on August 14...,with the requirements for continued listing on Th...e maintenance standard that specifies, among,other...s common stock be at,least $50 million as required...
... Crystal Research Associates, LLC,announced today ...view(R),(EIO(R)) on Generex Biotechnology Corporat...be found at http://www.crystalra.com ., Generex ...ny") is a,specialty pharmaceutical company that ai...livery systems and technologies to treat autoimmun...
Other Biology Technology:PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 2PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 3PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 4PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 5Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market 2Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market 3Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation 3
(Date:11/23/2009)...tute of General Medical Sciences (NIGMS), part of ...ing $42.3 million for grants in scientific areas i...veloped the GO grant program to stimulate biomedic...y the American Recovery and Reinvestment Act (Reco...romise to have a significant impact on a field of ...
(Date:11/23/2009)...vailable in German . , A bit of imagination... a bad thing. It could help to add data from areas...r, it must do so constructively. In order to infer...more than just imagination, physicists at the Max ...a theory of spatial perception called information ...
(Date:11/22/2009)...ng South Korean scientists have succeeded in produ...gh bioengineering, rather than through the use of ...esearch, which may now allow for the production of...in two papers in the journal Biotechnology and Bi...ry. , Polymers are molecules found in everyday ...
Breaking Biology News(10 mins):NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Visual assistance for cosmic blind spots 2Visual assistance for cosmic blind spots 3Visual assistance for cosmic blind spots 4Bioengineers succeed in producing plastic without the use of fossil fuels 2BioMarin to Present at the Baird Healthcare Conference 13799 1BioMarin to Present at the Baird Healthcare Conference 13799 2Kids Fight Cancer Announces 25th Annual Gala to Support Children 26apos 3Bs Memorial Hospital 55999 1Kids Fight Cancer Announces 25th Annual Gala to Support Children 26apos 3Bs Memorial Hospital 55999 2Kids Fight Cancer Announces 25th Annual Gala to Support Children 26apos 3Bs Memorial Hospital 55999 3Special Needs Equipment Rentals Save the Day for Travelers with Physical Disabilities 55997 1Special Needs Equipment Rentals Save the Day for Travelers with Physical Disabilities 55997 2Special Needs Equipment Rentals Save the Day for Travelers with Physical Disabilities 55997 3
...ing fish are no strangers to Americans. From the c... the children,s Disney favorite, "Nemo," fish can ... and the silver screen. But can real fish verbally...ublished in the July 18 issue of the journal Scie...social communications of all vertebrates--in evolu...
...AGO) Neurological experts from across the U.S. an...researcher from Rush University Medical Center wil...l research for Fragile X at the 11th International.... Louis. Families with children who are diagnosed...nce., Fragile X, an X-chromosome-linked condition,...
...lulu, HI A new indicator of coral health has been...elled algae called dinoflagellates. The study, rel...eedings of the National Academy of Sciences, reve...corals more susceptible to disease. , "Corals ar...t on dinoflagellates that live inside the coral,s ...
Other Biology News:Researcher helping to pioneer medical therapy for Fragile X Syndrome presents latest findings 2New indicator uncovered that can predict coral health 2New indicator uncovered that can predict coral health 3
Mouse Anti-p230 trans Golgi Monoclonal Antibody, Unconjugated, Clone 15 from BD Biosciences Pharmingen
...s intensely fluorescent and highly photostable Flu...use in a variety of applications requiring probes ...rotein- and other macromolecule-labeled microspher... bind to non-target surfaces in some applications....
DNA Polymerase I Large (Klenow) Fragment from Invitrogen
...chium album Description: Proteinase K is a high...range of applications purified from the fungus T. ...he carboxyl group of N-substituted hydrophobic ali...fied as a serine protease. Proteinase K is useful ...
Biology Products: